Therapeutic area
Other
Diagnostics, tools, and programs the classifier has not placed in one of the disease areas above.
0 pre-ticker companies classified in other right now.
Pipeline by stage
Where these companies sit on the ladder from a first grant to an approved product. Derived from evidence in public filings, never inferred past it.
No companies are classified in this area yet. During backfill the graph is still filling in.
Highest momentum in other
Not included in your seat
Other is outside your seat
The counts above are public. The ranked companies, their momentum, and their dossiers in Other follow your seat. The free tier covers oncology; a Fund or Feed seat covers every area, and an Analyst seat can be switched to other from your account.
Counts are public federal records; momentum is a recency-weighted score over public filing events, shown identically to every viewer. Informational only, not investment advice. All areas · Methodology